BTDR vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

BTDR

51.7
AI Score
VS
HIVE Wins

HIVE

57.7
AI Score

Investment Advisor Scores

BTDR

52score
Recommendation
HOLD

HIVE

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BTDR HIVE Winner
Forward P/E 8.8261 62.8931 BTDR
PEG Ratio 0 0 Tie
Revenue Growth 47.1% 73.5% HIVE
Earnings Growth 0.0% -99.9% BTDR
Tradestie Score 51.7/100 57.7/100 HIVE
Profit Margin -28.1% -98.5% BTDR
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BTDR 1M: -40.3% · 3M: -36.5% HIVE 1M: -43.0% · 3M: -35.1%

Current Technical Phase

BTDR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.5%), weak momentum, RSI 28

RSI (14): 28.1 · Price: $7.35

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 23

RSI (14): 23.3 · Price: $1.92

Fundamentals Snapshot

Metric BTDR HIVE
Market Cap — —
Forward P/E -21.6 -4.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.5% 0.7%
Gross Margin 0.0% 0.4%
Operating Margin -0.3% -0.6%
EPS -2.59 -1.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.